Literature DB >> 23997241

NCCN Task Force Report: Bone Health In Cancer Care.

Julie R Gralow, J Sybil Biermann, Azeez Farooki, Monica N Fornier, Robert F Gagel, Rashmi Kumar, Georgia Litsas, Rana McKay, Donald A Podoloff, Sandy Srinivas, Catherine H Van Poznak.   

Abstract

Bone health and maintenance of bone integrity are important components of comprehensive cancer care. Many patients with cancer are at risk for therapy-induced bone loss, with resultant osteoporotic fractures, or skeletal metastases, which may result in pathologic fractures, hypercalcemia, bone pain, and decline in motility and performance status. Effective screening and timely interventions are essential for reducing bone-related morbidity. Management of long-term bone health requires a broad knowledge base. A multidisciplinary health care team may be needed for optimal assessment and treatment of bone-related issues in patients with cancer. Since publication of the previous NCCN Task Force Report: Bone Health in Cancer Care in 2009, new data have emerged on bone health and treatment, prompting NCCN to convene this multidisciplinary task force to discuss the progress made in optimizing bone health in patients with cancer. In December 2012, the panel members provided didactic presentations on various topics, integrating expert judgment with a review of the key literature. This report summarizes issues surrounding bone health in cancer care presented and discussed during this NCCN Bone Health in Cancer Care Task Force meeting.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23997241     DOI: 10.6004/jnccn.2013.0215

Source DB:  PubMed          Journal:  J Natl Compr Canc Netw        ISSN: 1540-1405            Impact factor:   11.908


  61 in total

Review 1.  Imaging of bone metastasis: An update.

Authors:  Gerard J O'Sullivan; Fiona L Carty; Carmel G Cronin
Journal:  World J Radiol       Date:  2015-08-28

2.  Long-term oral bisphosphonate use in relation to fracture risk in postmenopausal women with breast cancer: findings from the Women's Health Initiative.

Authors:  Rebecca L Drieling; Andrea Z LaCroix; Shirley A A Beresford; Denise M Boudreau; Charles Kooperberg; Rowan T Chlebowski; Margery Gass; Carolyn J Crandall; Catherine R Womack; Susan R Heckbert
Journal:  Menopause       Date:  2016-11       Impact factor: 2.953

Review 3.  Skeletal manifestations of treatment of breast cancer on premenopausal women.

Authors:  Loomee Doo; Charles L Shapiro
Journal:  Curr Osteoporos Rep       Date:  2013-12       Impact factor: 5.096

4.  Adjuvant endocrine therapy in premenopausal women with breast cancer.

Authors:  Kunal C Kadakia; N Lynn Henry
Journal:  Clin Adv Hematol Oncol       Date:  2015-10

5.  Mind the gaps: missed opportunities to promote bone health among cancer survivors.

Authors:  Hawley C Almstedt; Heather P Tarleton
Journal:  Support Care Cancer       Date:  2014-11-05       Impact factor: 3.603

Review 6.  Medication-induced osteoporosis: screening and treatment strategies.

Authors:  Keshav Panday; Amitha Gona; Mary Beth Humphrey
Journal:  Ther Adv Musculoskelet Dis       Date:  2014-10       Impact factor: 5.346

Review 7.  Cytoreduction for colorectal metastases: liver, lung, peritoneum, lymph nodes, bone, brain. When does it palliate, prolong survival, and potentially cure?

Authors:  Camille L Stewart; Susanne Warner; Kaori Ito; Mustafa Raoof; Geena X Wu; Jonathan Kessler; Jae Y Kim; Yuman Fong
Journal:  Curr Probl Surg       Date:  2018-10-04       Impact factor: 1.909

8.  Endocrine therapy for breast cancer in the primary care setting.

Authors:  A Awan; K Esfahani
Journal:  Curr Oncol       Date:  2018-08-14       Impact factor: 3.677

9.  Assessing the prevalence of compromised bone health among overweight and obese African-American breast cancer survivors: a case-control study.

Authors:  Patricia Sheean; Huifang Liang; Linda Schiffer; Claudia Arroyo; Karen Troy; Melinda Stolley
Journal:  J Cancer Surviv       Date:  2015-03-29       Impact factor: 4.442

Review 10.  Drug-Induced Hypophosphatemia: Current Insights.

Authors:  Efstathia Megapanou; Matilda Florentin; Haralampos Milionis; Moses Elisaf; George Liamis
Journal:  Drug Saf       Date:  2020-03       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.